文献速递妇产影像儿科影像US

单核苷酸多态性微阵列在产前诊断中检出的杂合性缺失

Absence of heterozygosity detected by single-nucleotide polymorphism array in prenatal diagnosis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2021-01-07

伴超声异常者不良围产结局率30/48(62.5%),高于无超声异常者的6/40(15.0%)(P < 0.001)。作者提出对AOH产前诊断应结合系列超声、父母验证、全外显子组测序、胎盘研究和有效随访综合评估。

要点

  • AOH可累及所有染色体,X、2和16号染色体最常受累,长度从部分染色体(9.002-80.222 Mb)到整条染色体。
  • 伴超声异常的AOH胎儿不良围产结局率62.5%(30/48),高于无超声异常者的15.0%(6/40)(P < 0.001)。

关键影像表现/征象

  • AOH可出现在所有染色体,X、2和16号染色体最常受累。
  • AOH长度从部分染色体(9.002-80.222 Mb)到整条染色体不等。
  • 相似的AOH区域可表现为不同的临床表现。
  • 55例患者伴超声异常,最常见为多发异常(14/55(25.5%))、泌尿生殖系统畸形(8/55(14.5%))、骨骼畸形(5/55(9.1%))和小于胎龄儿(5/55(9.1%))。

诊断标准与关键数值

  • AOH定义为拷贝数中性的染色体纯合片段,对AOH超过10 Mb或疑似致病者进一步分析。
  • 100例(0.97%)检出AOH,其中81例(81.0%)为单条染色体AOH,19例(19.0%)为不同染色体多发AOH。
  • 伴超声异常的AOH胎儿不良围产结局(包括终止妊娠、新生儿死亡、胎死宫内、选择性减胎和流产)率为30/48(62.5%),高于无超声异常者的6/40(15.0%)(P < 0.001)。
  • 对母血游离胎儿DNA行无创产前检测提示11例染色体拷贝数异常,但经羊水SNP阵列证实为AOH。

临床应用与阅片要点

  • SNP阵列可识别拷贝数中性的AOH,对无创产前检测提示的染色体拷贝数异常需经羊水SNP阵列确认是否为AOH。
  • 作者提出对产前AOH应综合评估,管理策略包括进一步系列超声检查、父母验证、全外显子组测序、胎盘研究和有效随访。

局限性

  • 作者指出产前AOH的遗传咨询仍具挑战性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the general occurrence and clinical significance of absence of heterozygosity (AOH), detected by single-nucleotide polymorphism (SNP) array on prenatal diagnosis.

METHODS: We recruited pregnancies undergoing invasive prenatal diagnosis at our fetal medicine center over a 6-year period. All fetuses underwent SNP array using the Affymetrix CytoScan HD array platform. AOH was defined as a chromosomal homozygosity segment with neutral copy number. Cases with AOH over 10 Mb in size or with suspected pathogenicity were further analyzed, and the clinical features and outcome were reviewed.

RESULTS: Of 10 294 recruited fetuses, 100 (0.97%) with AOH were identified; in 81 (81.0%) of these, AOH occurred in a single chromosome, while 19 (19.0%) patients had multiple AOHs in different chromosomes. AOH was observed in all chromosomes, chromosomes X, 2 and 16 being the most frequently involved. The length of AOH ranged from partial chromosome (9.002-80.222 Mb) to the entire chromosome. Similar AOH regions displayed varied clinical manifestations. In total, 55 patients presented with concomitant ultrasound abnormalities, the most common being multiple abnormalities (14/55 (25.5%)), genitourinary malformations (8/55 (14.5%)), skeletal malformations (5/55 (9.1%)) and small-for-gestational age (5/55 (9.1%)). Notably, the rate of adverse perinatal outcome (including termination of pregnancy, neonatal death, fetal death, selective reduction and miscarriage) in fetuses with AOH and ultrasound abnormalities (30/48 (62.5%)) was higher than in those without ultrasound abnormalities (6/40 (15.0%)) (P < 0.001). Further non-invasive prenatal testing using cell-free fetal DNA from maternal blood indicated chromosomal copy number abnormalities in 11 patients; however, they were confirmed as AOH by SNP array of the amniotic fluid.

CONCLUSIONS: Genetic counseling regarding a prenatal diagnosis of AOH remains challenging. To evaluate comprehensively its significance, we propose a management strategy involving further serial ultrasound examinations, parental verification, whole-exome sequencing, placental study and effective follow-up. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Liu J, He Z, Lin S, et al. Absence of heterozygosity detected by single-nucleotide polymorphism array in prenatal diagnosis. Ultrasound Obstet Gynecol. 2021. PMID: 31840905. doi:10.1002/uog.21951

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。